Platelet-mediated vascular permeability in the rat: A predominant role for 5-hydroxytryptamine
- 15 May 1985
- journal article
- Published by Elsevier BV in Thrombosis Research
- Vol. 38 (4), 321-339
- https://doi.org/10.1016/0049-3848(85)90132-x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Inhibition of 5-hydroxytryptamine-induced and-amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonistInflammation Research, 1982
- A Microscopic Study of Inflammatory Reactions in Human Skin Induced by Histamine and Compound 48/80Journal of Investigative Dermatology, 1982
- Localization within a thin optical section of fluorescent blood platelets flowing in a microvesselMicrovascular Research, 1982
- Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptorsLife Sciences, 1981
- Vascular Anti‐permeability Effects of β‐receptor Agonists and Theophylline in the LungActa Pharmacologica et Toxicologica, 1979
- The modulation of enhanced vascular permeability by prostaglandins through alterations in blood flow (hyperemia)Inflammation Research, 1976
- Interactions of bradykinin, prostaglandin E1, 5-hydroxytryptamine, histamine and adenosine-5′-triphosphate on the dye leakage response in rat skinJournal of Pharmacy and Pharmacology, 1976
- INFLAMMATORY EFFECTS OF PROSTAGLANDIN D2 IN RAT AND HUMAN SKINBritish Journal of Pharmacology, 1976
- A simple routine-method to preserve and determine blood serotoninCellular and Molecular Life Sciences, 1974
- Characterization of Human Platelet Vascular Permeability-Enhancing ActivityJCI Insight, 1972